ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OSCR Oscar Health Inc

17.50
-0.39 (-2.18%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Oscar Health Inc NYSE:OSCR NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.39 -2.18% 17.50 18.20 17.52 18.05 2,619,275 01:00:00

OSCR SHAREHOLDER ALERT: Jakubowitz Law Reminds Oscar Shareholders of a Lead Plaintiff Deadline of July 11, 2022

01/07/2022 10:45am

PR Newswire (US)


Oscar Health (NYSE:OSCR)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Oscar Health Charts.

NEW YORK, July 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Oscar Health, Inc. (NYSE: OSCR).

To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/oscar-health-inc-loss-submission-form/?id=29407&from=4

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.

Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until July 11, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

According to a filed complaint, Oscar Health, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

Cision View original content:https://www.prnewswire.com/news-releases/oscr-shareholder-alert-jakubowitz-law-reminds-oscar-shareholders-of-a-lead-plaintiff-deadline-of-july-11-2022-301579232.html

SOURCE Jakubowitz Law

Copyright 2022 PR Newswire

1 Year Oscar Health Chart

1 Year Oscar Health Chart

1 Month Oscar Health Chart

1 Month Oscar Health Chart

Your Recent History

Delayed Upgrade Clock